biapenem
Sign in to saveAlso known as (4R,5S,6S)-3-(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazol-4-ium-6-ylthio)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate, 6-[[(4R,5S,6S)-2-Carboxy-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-en-3-yl]thio]-6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazol-4-ium inner salt
Biapenem (INN) is a carbapenem antibiotic. It has in vitro activity against anaerobes. 1-β-methyl-carbapenem antibiotic. Approved in Japan in 2001.
Research
347 papers- Biapenem.Drugs · 2002
- Biapenem.The Journal of the Association of Physicians of India · 2022
- Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy.Frontiers in pharmacology · 2020
- Carbapenems: past, present, and future.Antimicrobial agents and chemotherapy · 2011
- Efficacy and safety of biapenem in treatment of infectious disease: a meta-analysis of randomized controlled trials.Journal of chemotherapy (Florence, Italy) · 2016
via PubMed
~1 min read
Encyclopedic overview
2 sectionsContents
- References
- External links
Biapenem (INN) is a carbapenem antibiotic. It has in vitro activity against anaerobes. 1-β-methyl-carbapenem antibiotic. Approved in Japan in 2001.
== References ==
Excerpted from Wikipedia’s “biapenem” article, available under the CC BY-SA 4.0 licence.
Available in 9 languages
via Wikidata sitelinks · CC0